Skip to main content
Back to Lightspeed Venture Partners

Lightspeed Venture Partners's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by Lightspeed Venture Partners. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$514.4M

Pharmaceutical Portfolio Companies (5)

Export
BiopharmaBiotechnologyHealth CarePharmaceutical

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Boston, United States
September 2023
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Schlieren, Switzerland
September 2024
$11.0M
Series C

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

Menlo Park, United States
January 2026
$250.0M
Series F

Founder Contacts

30,000+ verified contacts

DeliveryHealth CarePharmaceutical

MAYD Group operates as a startup that delivers medicines in minutes.

Berlin, Germany
January 2022
$33.4M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Lexington, United States
December 2025
$120.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore Lightspeed Venture Partners's Full Portfolio

View all companies funded by Lightspeed Venture Partners across every industry and funding stage.

View Full Lightspeed Venture Partners Portfolio